12.11.23 -- Alex Gorsky On Leadership Skills

Introducing Advancing RNA, an online community designed to be a forum and resource for professionals working on RNA-based therapeutics to better understand the challenges that confront them in areas like Analytical/Quality, Manufacturing, Formulation, Outsourcing, Clinical Research, and Supply Chain/Logistics. Sign up for the Advancing RNA newsletter, delivered to your inbox weekly.

Vittoria Biotherapeutics’ CEO Nick Siciliano joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss the company's mission to expand the applications for CAR-based therapeutics by employing novel cell engineering and gene editing technologies. Listen now!

Drug development is slow and costly. Learn how a state-of-the-art system can increase efficiency and ROI by providing valuable data insights and superior customer service.

The decision whether to develop and manufacture a drug in-house or to outsource comprises numerous elements, including costs, timelines, production capacity, and available resources.

As the industry looks forward, key decision makers in pharma and biotech companies were surveyed to assess their views on undertaking regulatory processes virtually.

Review what the president and CEO of a clinical-stage genomic medicines company had to say about growth strategy and his progress in the pursuit of gene therapies to address inherited retinal diseases.

See how the EU joint health technology assessment regulation (HTAR) and finalization of the pharma legislation review can help to use resources more efficiently and reduce the time span of assessments.